← Back to Search

PROM symptom tracker for Gynecologic Cancers

N/A
Waitlist Available
Led By Shitanshu Uppal, MBBS
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30-32 days post-operative
Awards & highlights

Study Summary

This trial is testing a new way of monitoring patients at home after surgery, using text messages to check in on symptoms and get automated responses on what to do next.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30-32 days post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-32 days post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean total score on FACT-G
Secondary outcome measures
Proportion of patients readmitted to hospital
Proportion of patients seen in emergency room
Proportion of patients seen in urgent care clinics
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard Post-Operative Counseling + PROM survey + FACT-G (Intervention Arm)Experimental Treatment2 Interventions
Patients will receive the standard postoperative counseling at discharge, discharge instructions, and the link to website with postoperative instructions. The intervention arm will receive and complete the Patient-Reported Outcome Measure (PROM) survey via the SMS text messaging service on a set schedule. Patients will complete the FACT-G.
Group II: Standard Post-Operative Counseling + FACT-G (Control Arm)Active Control1 Intervention
Patients will receive the standard postoperative counseling at discharge, discharge instructions, and the link to website with postoperative instructions. Patients will complete the Functional Assessment of Cancer Therapy - General (FACT-G).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard Post-Operative Counseling + FACT-G
2022
N/A
~110
PROM symptom tracker
2022
N/A
~110

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
293 Previous Clinical Trials
23,995 Total Patients Enrolled
2 Trials studying Gynecologic Cancers
80 Patients Enrolled for Gynecologic Cancers
Shitanshu Uppal, MBBSPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
62 Total Patients Enrolled
1 Trials studying Gynecologic Cancers
62 Patients Enrolled for Gynecologic Cancers

Media Library

PROM symptom tracker Clinical Trial Eligibility Overview. Trial Name: NCT04852471 — N/A
Gynecologic Cancers Research Study Groups: Standard Post-Operative Counseling + PROM survey + FACT-G (Intervention Arm), Standard Post-Operative Counseling + FACT-G (Control Arm)
Gynecologic Cancers Clinical Trial 2023: PROM symptom tracker Highlights & Side Effects. Trial Name: NCT04852471 — N/A
PROM symptom tracker 2023 Treatment Timeline for Medical Study. Trial Name: NCT04852471 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you tell me if there are any vacancies in this research program?

"Data posted to clinicaltrials.gov indicates that this medical study is actively recruiting patients, having first been advertised on the 5th of January 2022 and most recently updated on the 8th of July 2022."

Answered by AI

How many people are participating in this clinical experiment?

"Affirmative, the information available on clinicaltrials.gov indicates that this medical study is actively recruiting participants. The trial was posted at the beginning of January 2022 and recently updated in early July 20202. 162 patients need to be recruited for 1 location."

Answered by AI
~31 spots leftby Apr 2025